Fredun Pharmaceuticals Limited (FREDUN)

BSE: ₹2,301.95
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 61.23 81.48 86.65 117.21 77.54 106.89 101.84 165.44 119.40 143.59 159.93 210.41
YOY Revenue Growth % 15.26% 17.33% 11.6% 47.02% 26.64% 31.19% 17.52% 41.14% 54% 34.33% 57.04% 27.19%
Other Income 0.82 0.50 0.35 0.82 1.28 0.46 0.86 1.97 0.45 1.71 1.00 2.64
Total Income 62.05 81.99 87.01 118.03 78.81 107.35 102.70 167.41 119.86 145.29 160.92 213.05
Total Expenses + 57.97 76.22 81.24 112.19 73.29 99.78 95.56 159.37 110.81 132.29 146.92 201.52
Cost of Materials Consumed 34.44 81.67 75.56 91.57 57.88 67.40 72.66 125.01 91.08 99.26 118.91 173.54
Employee Benefit Expense 2.69 2.93 2.97 3.90 3.10 3.58 5.85 9.70 7.63 8.30 8.15 8.86
Other Expenses 6.53 7.03 10.02 13.30 7.68 14.55 11.22 16.49 10.81 10.99 14.88 23.61
Operating Profit 3.26 5.26 5.41 5.02 4.24 7.11 6.28 6.07 8.59 11.30 13.01 8.89
OPM % 5.3% 6.5% 6.2% 4.3% 5.5% 6.7% 6.2% 3.7% 7.2% 7.9% 8.1% 4.2%
Profit Before Tax + 4.08 5.77 5.76 5.84 5.52 7.58 7.13 8.04 9.04 13.01 14.00 11.53
Tax Expense 1.68 1.83 1.54 0.78 1.39 3.30 1.80 0.97 2.27 3.27 3.52 0.47
Tax % 41.1% 31.8% 26.7% 13.3% 25.2% 43.6% 25.3% 12.1% 25.2% 25.2% 25.2% 4.1%
Profit After Tax 2.40 3.94 4.22 5.06 4.13 4.27 5.33 7.07 6.77 9.73 10.48 11.07
EPS (Basic) 5.24 8.40 8.99 10.77 8.79 9.05 11.29 14.98 14.33 20.61 19.53 20.22

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 633.33 451.71 346.58 274.34 221.74 131.55
YOY Revenue Growth % 40.21% 30.33% 26.33% 23.72% 68.55% -
Other Income 5.80 4.56 2.49 2.16 4.35 3.74
Total Income 639.12 456.27 349.07 276.50 226.09 135.29
Total Expenses + 591.54 428.00 327.62 258.99 217.49 130.92
Cost of Materials Consumed 480.76 323.98 282.42 245.57 176.45 100.60
Employee Benefit Expense 32.94 22.23 12.50 11.53 10.66 8.66
Other Expenses 62.32 48.91 37.69 27.52 23.56 14.33
Operating Profit 41.79 23.71 18.96 15.35 4.25 0.63
OPM % 6.6% 5.2% 5.5% 5.6% 1.9% 0.5%
Profit Before Exceptional 47.58 28.27 21.45 17.51 8.60 4.37
Exceptional Items 0.00 0.00 0.00 0.00 0.00 -1.16
Profit Before Tax + 47.58 28.27 21.45 17.51 8.60 3.21
Tax Expense 14.38 7.46 5.83 6.70 2.26 1.19
Tax % 30.2% 26.4% 27.2% 38.3% 26.3% 37.2%
Profit After Tax 33.21 20.81 15.62 10.81 6.34 2.01
EPS (Basic) 68.01 44.83 33.66 22.93 14.29 5.05

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 143.89 59.12 50.40 41.07 34.34 31.54
Property, Plant & Equipment 117.61 52.14 46.15 38.63 32.28 30.32
Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00
Non-Current Investments 0.00 0.76 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.43 0.42 0.31 0.06 0.03
Current Assets + 498.24 427.53 257.20 216.21 152.65 130.08
Inventories 269.80 239.89 175.00 150.12 46.46 67.57
Trade Receivables 92.69 177.12 64.85 34.56 90.27 41.08
Cash and Cash Equivalents 64.90 0.23 1.07 2.95 1.94 0.99
Current Investments 0.00 0.75 0.81 0.31 0.06 0.06
LIABILITIES & EQUITY
Total Equity 278.71 141.40 121.47 96.38 68.06 43.07
Equity Share Capital 5.47 4.72 4.70 4.53 4.43 3.99
Other Equity 273.24 136.68 116.77 91.84 63.63 39.08
Non-Current Liabilities 67.11 17.93 11.65 54.74 45.18 32.09
Current Liabilities 296.31 327.32 174.47 106.17 73.75 86.46
Total Liabilities 363.43 345.25 186.13 160.90 118.93 118.55

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 30.81 -28.88 -0.44 -14.41 -2.38 -13.08
Cash from Investing Activities -73.58 -5.99 -7.64 -9.40 -4.14 -0.84
Cash from Financing Activities 121.82 38.34 5.99 25.18 7.47 17.52
Net Increase/Decrease in Cash 79.05 3.47 -2.08 1.36 0.94 3.60